American Century Ultra Fund Q3 2025 Contributors/Detractors And Notable TradesSeeking Alpha • 11/30/25
S&P 500 Retailer Leads Five Resilient Stocks After Nvidia-Led Market Sell-OffInvestors Business Daily • 11/22/25
Highflying Biotech Stock Sets Up After 96% Pop; Annual Profit In Sight As Key Drug Sales DoubleInvestors Business Daily • 11/20/25
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/19/25
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 11/18/25
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CMBusiness Wire • 11/08/25
American Century Focused Dynamic Growth Fund Q3 2025 Performance Contributors And DetractorsSeeking Alpha • 11/05/25
Biotech is back. Here's why these rallying stocks belong in your portfolio now.Market Watch • 11/03/25
Alnylam Pharmaceuticals: Q3 Earnings Review - A Sensational Year Reaches Its PeakSeeking Alpha • 10/31/25
ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra SalesZacks Investment Research • 10/31/25
Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.Investors Business Daily • 10/30/25
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period ProgressBusiness Wire • 10/30/25
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 10/28/25